Category: Diseases & Conditions
Global Diseases & Conditions
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Protective Eyewear
... CAGR of 4.6% over the analysis period 2024-2030. Non-Prescription Protective Eyewear, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Ceramic Inks
... CAGR of 6.1% over the analysis period 2024-2030. Decorative Inks, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Cereal Bars
... CAGR of 7.7% over the analysis period 2024-2030. Snack Bars, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$20.7 Billion by the end of the analysis ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Coconut Milk
... CAGR of 16.1% over the analysis period 2024-2030. Conventional Coconut Milk, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Contract Packaging
... CAGR of 8.7% over the analysis period 2024-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$55.4 Billion by the end of ... Read More
-
Enterprise Governance, Risk and Compliance (EGRC)
... reach US$194.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach ... Read More
-
Exterior Insulation and Finish Systems (EIFS)
... reach US$173.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Polymer-based EIFS, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Fruit Flavor, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$24.1 Billion by the end of the analysis ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Intraoperative Radiation Therapy
... at a CAGR of 6.0% over the analysis period 2024-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$22.9 Million by the end ... Read More
-
Medical Refrigerators
... CAGR of 7.0% over the analysis period 2024-2030. Blood Bank Refrigerator & Plasma Freezer, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.6 Billion by the ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of ... Read More
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel Devices, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Bone Densitometers
... CAGR of 5.6% over the analysis period 2024-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$264.5 Million by the end of the ... Read More
-
Migraine Drugs
... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Limestone
... 3.9% over the analysis period 2024-2030. Construction End-Use, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$84.8 Billion by the end of the analysis period. Growth ... Read More
-
Pain Management Devices
... at a CAGR of 7.8% over the analysis period 2024-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
qPCR Reagents
... CAGR of 7.4% over the analysis period 2024-2030. Dye-Based qPCR Reagents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Livestock Monitoring
... CAGR of 9.5% over the analysis period 2024-2030. Livestock Monitoring Hardware, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Low VOC Paints
... at a CAGR of 5.8% over the analysis period 2024-2030. Water-Borne Formulation, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$10.7 Billion by the end of ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end ... Read More
Research Assistance
